CACC 154.40 Credit Acceptance Corp $CACC Hit a 52 week high

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
CACC 154.40 Credit Acceptance Corp $CACC Hit a 52 week high of 155.00 Currently at 154.40 +1.46 +0.95% With a day low of 152.01 and a total volume of 60,500.

CACC Credit Acceptance Corp Recent Headline News

Credit Acceptance Has Returned 22.3% Since SmarTrend Recommendation (CACC)
Comtex SmarTrend(R) - Wed Nov 05, 9:41AM CST
SmarTrend identified an Uptrend for Credit Acceptance (NASDAQ:CACC) on August 12th, 2014 at $122.51. In approximately 3 months, Credit Acceptance has returned 22.28% as of today's recent price of $149.80.
CACC: 154.40 (+1.46)

Credit Acceptance Announces Third Quarter 2014 Earnings
GlobeNewswire - Wed Oct 29, 3:13PM CDT
Credit Acceptance Corporation (NASDAQ: CACC) (referred to as the "Company", "Credit Acceptance", "we", "our", or "us" today announced consolidated net income of $74.0 million, or $3.38 per diluted share, for the three months ended September 30, 2014 compared to consolidated net income of $65.1 million, or $2.75 per diluted share, for the same period in 2013. For the nine months ended September 30, 2014, consolidated net income was $193.2 million, or $8.48 per diluted share, compared to consolidated net income of $187.2 million, or $7.78 per diluted share, for the same period in 2013.
CACC: 154.40 (+1.46)

Uptrend Call Working As Credit Acceptance Stock Rises 11.8% (CACC)
Comtex SmarTrend(R) - Wed Oct 29, 9:29AM CDT
SmarTrend identified an Uptrend for Credit Acceptance (NASDAQ:CACC) on August 12th, 2014 at $122.51. In approximately 3 months, Credit Acceptance has returned 11.83% as of today's recent price of $137.00.
CACC: 154.40 (+1.46)

Credit Acceptance Announces Final Results of Tender Offer
GlobeNewswire - Fri Oct 24, 7:00AM CDT
Credit Acceptance Corporation (NASDAQ: CACC) (referred to as the "Company", "Credit Acceptance", "we", "our", or "us" announced today the final results of our tender offer, which expired at 5:00 p.m., New York City time, on October 20, 2014. We commenced the tender offer on September 19, 2014 to purchase up to 995,698 shares of our outstanding common stock at a price of $125.54 per share, net to the seller in cash, without interest. Based on the final count by Computershare Trust Company, N.A., the Depositary for the tender offer, 8,891,295 shares of common stock were properly tendered and not properly withdrawn. Because more than the maximum 995,698 shares were tendered, we have accepted for purchase only a prorated portion of the shares tendered by each tendering shareholder, other than odd lot shareholders, as described in our Offer to Purchase. The proration factor used by us in accepting for purchase tendered shares was approximately 10.8%.
CACC: 154.40 (+1.46)

Credit Acceptance Announces Timing of Third Quarter 2014 Earnings Release and Webcast
GlobeNewswire - Wed Oct 22, 3:05PM CDT
Credit Acceptance Corporation (NASDAQ: CACC) (referred to as the "Company", "Credit Acceptance", "we", "our", or "us" announced today that we expect to issue a news release with our third quarter 2014 earnings on Wednesday, October 29, 2014, after the market closes.
CACC: 154.40 (+1.46)

Credit Acceptance Announces Preliminary Results of Tender Offer
GlobeNewswire - Tue Oct 21, 7:12AM CDT
Credit Acceptance Corporation (NASDAQ: CACC) (referred to as the "Company", "Credit Acceptance", "we", "our", or "us" announced today the preliminary results of our tender offer, which expired at 5:00 p.m., New York City time, on October 20, 2014. We commenced the tender offer on September 19, 2014 to purchase up to 995,698 shares of our outstanding common stock at a price of $125.54 per share, net to the seller in cash, without interest. Georgeson, Inc. acted as Information Agent for the tender offer and Computershare Trust Company, N.A. acted as the Depositary.
CACC: 154.40 (+1.46)

Credit Acceptance Announces Certain Operating Results
GlobeNewswire - Tue Oct 07, 3:05PM CDT
Credit Acceptance Corporation (NASDAQ: CACC) (referred to as the "Company", "Credit Acceptance", "we", "our", or "us" announced today certain operating results in connection with our previously announced tender offer to purchase up to 995,698 shares of our outstanding common stock at a price of $125.54 per share. The tender offer will expire at 5:00 p.m., New York City time, on Monday, October 20, 2014, unless extended by us.
CACC: 154.40 (+1.46)

Cheap Stocks Wall Street Hates: Credit Acceptance Corporation
Jordan Wathen, The Motley Fool - Motley Fool - Mon Oct 06, 9:20AM CDT
Throughout its public history, Credit Acceptance Corporation  has been cheap by most valuation metrics. Today, it sells for just 11 times earnings, with expectations for five-year forward earnings growth of 11%. That gives it a PEG ratio of roughly...
CACC: 154.40 (+1.46)

Credit Acceptance Announces Completion of $349.0 Million Asset-Backed Financing
GlobeNewswire - Thu Sep 25, 3:10PM CDT
Credit Acceptance Corporation (NASDAQ: CACC) (the "Company", "Credit Acceptance", "we", "our", or "us" announced today the completion of a $349.0 million asset-backed non-recourse secured financing (the "Financing". Pursuant to this transaction, we contributed loans having a net book value of approximately $437.6 million to a wholly-owned special purpose entity which will transfer the loans to a trust, which will issue three classes of notes:
CACC: 154.40 (+1.46)

Credit Acceptance Announces Tender Offer
GlobeNewswire - Fri Sep 19, 6:59AM CDT
Credit Acceptance Corporation (NASDAQ: CACC)(referred to as the "Company", "Credit Acceptance", "we", "our", or "us" announced today that we have commenced a tender offer to purchase up to 995,698 shares of our outstanding common stock at a price of $125.54 per share.
CACC: 154.40 (+1.46)

Kroll Bond Rating Agency Assigns Preliminary Ratings to Credit Acceptance Auto Loan Trust 2014-2
Business Wire - Tue Sep 16, 9:45AM CDT
Kroll Bond Rating Agency (KBRA) assigns preliminary ratings to two classes of Credit Acceptance Auto Loan Trust 2014-2 ("CAALT 2014-2", an auto loan asset-backed securities transaction.
CACC: 154.40 (+1.46)

Credit Acceptance Announces Extension of Revolving Secured Warehouse Facility
GlobeNewswire - Mon Sep 15, 4:10PM CDT
Credit Acceptance Corporation (NASDAQ: CACC) (referred to as the "Company", "Credit Acceptance", "we", "our", or "us" announced today we extended the date on which our $75.0 million revolving secured warehouse facility will cease to revolve from September 10, 2015 to September 10, 2017. The maturity of the facility was also extended from September 10, 2017 to September 10, 2019. There were no other material changes to the terms of the facility.
CACC: 154.40 (+1.46)

Credit Acceptance Has Returned 8.9% Since SmarTrend Recommendation (CACC)
Comtex SmarTrend(R) - Mon Aug 11, 12:53PM CDT
SmarTrend identified a Downtrend for Credit Acceptance (NASDAQ:CACC) on April 7th, 2014 at $133.79. In approximately 4 months, Credit Acceptance has returned 8.92% as of today's recent price of $121.86.
CACC: 154.40 (+1.46)

14.1% Return Seen to Date on SmarTrend Credit Acceptance Call (CACC)
Comtex SmarTrend(R) - Mon Aug 04, 9:44AM CDT
SmarTrend identified a Downtrend for Credit Acceptance (NASDAQ:CACC) on April 7th, 2014 at $133.79. In approximately 4 months, Credit Acceptance has returned 14.12% as of today's recent price of $114.90.
CACC: 154.40 (+1.46)

Credit Acceptance Announces Second Quarter 2014 Earnings
GlobeNewswire - Wed Jul 30, 3:15PM CDT
Credit Acceptance Corporation (NASDAQ: CACC) (referred to as the "Company", "Credit Acceptance", "we", "our", or "us" today announced consolidated net income of $69.4 million, or $3.06 per diluted share, for the three months ended June 30, 2014 compared to consolidated net income of $61.5 million, or $2.56 per diluted share, for the same period in 2013. For the six months ended June 30, 2014, consolidated net income was $119.2 million, or $5.15 per diluted share, compared to consolidated net income of $122.1 million, or $5.04 per diluted share, for the same period in 2013.
CACC: 154.40 (+1.46)

Will Hartford Financial (HIG) Beat Q2 Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 29, 3:20PM CDT
The Hartford Financial Services Group, Inc. (HIG) is set to report second-quarter 2014 earnings results on Jul 30, 2014.
SC: 17.21 (+0.12), CACC: 154.40 (+1.46), ACGL: 57.48 (+0.40), HIG: 40.20 (+0.29)

Will International Paper (IP) Surprise this Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 28, 12:40PM CDT
International Paper Company (IP) is scheduled to report its second-quarter 2014 results before the opening bell on Jul 29.
CHRW: 71.46 (-0.14), CACC: 154.40 (+1.46), IP: 52.87 (+0.40), AGNC: 22.55 (+0.13)

Credit Acceptance Shares Down 11.6% Since SmarTrend's Sell Call (CACC)
Comtex SmarTrend(R) - Mon Jul 28, 9:26AM CDT
SmarTrend identified a Downtrend for Credit Acceptance (NASDAQ:CACC) on April 7th, 2014 at $133.79. In approximately 4 months, Credit Acceptance has returned 11.65% as of today's recent price of $118.21.
CACC: 154.40 (+1.46)

Is Xerox (XRX) Likely to Disappoint on Q2 Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 24, 4:30PM CDT
Xerox Corporation (XRX) is scheduled to report its second-quarter 2014 results before the opening bell on Jul 25.
CHRW: 71.46 (-0.14), CACC: 154.40 (+1.46), AGNC: 22.55 (+0.13), XRX: 13.45 (+0.15)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Step Inside Henson's Creature Shop Magic in NYC

Updated Category News Views 8

Unlock Puppet Magic with Jim Henson Tours Puppet fans, let me tell you, there's something going on in Queens, NY that's got both nostalgia and innovation scribbled all over it. We're talking about the legendary Jim Henson's Creature Shop opening its doors. If you're looking to relive the magic that helped shape a generation, get ready to dive into a world where creativity...

Continue Reading
Streamlined AI Video Analytics for Public Safety Unveiled

Updated Category News Views 2

AI Without the Headache Alright folks, IREX is shaking things up, and not in the usual iterative, bit-by-bit tech progression way. StreamVLM™ has been rolled out as the world's first vision-language model (VLM) analytics engine tailored for the public safety sector—specifically, for cloud platforms. I’ve been around the block enough times to spot a significant shift...

Continue Reading
Lick the Plate Hits 2,000 Shows with Clown Band

Updated Category News Views 5

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

Continue Reading
Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 4

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
Oil Markets Shift Focus: Pipelines Trump Drilling

Updated Category News Views 5

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

Continue Reading
Crystal Risotti: Leading IT Compliance in Healthcare

Updated Category News Views 6

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Continue Reading
Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Updated Category News Views 8

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

Continue Reading
XKL Delivers MediaLight for High-Speed Optical Transport

Updated Category News Views 5

Unpacking the MediaLight Launch Kicking off September, XKL is tossing its hat in the ring with the MediaLight Xponder and Muxponder systems. These aren't just any run-of-the-mill gizmos—nope, they're touted as top-of-the-line optical transport solutions. The talk of the town is their ability to dish out high-density 100G and 400G transport, and for geeks in the trade,...

Continue Reading
Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Updated Category News Views 4

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

Continue Reading
Fermi's Founder Pushes for Board Overhaul: What's Next?

Updated Category News Views 2

Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...

Continue Reading

Top 5 Most Recently Viewed Articles

LenioBio and ReciBioPharm Team Up for Vaccine Tech Advancement

Updated Category News Views 52

LenioBio and ReciBioPharm Team Up for Vaccine Tech Advancement LenioBio, known for its innovative approaches to rapid protein expression, has announced an exciting collaboration with ReciBioPharm, aiming to boost vaccine production and efficiency through advanced technology. This partnership is set to play a vital role in enhancing the capabilities of protein...

Continue Reading
Trump and Cuban's Rivalry Heats Up Amid Tariff Controversy

Updated Category News Views 172

Trump and Cuban's Feud Intensifies Donald Trump recently directed a fierce critique at billionaire Mark Cuban, accusing him of being a "loser" and labeling him as a "weak and pathetic bully." This latest insult arises from a public dispute ignited by Cuban's criticisms regarding Trump's proposed tariff strategies. The Catalyst of the Conflict The discord took a public...

Continue Reading
Cascale Revamps Engagement Model to Enhance Manufacturer Input

Updated Category News Views 77

Cascale Unveils New Membership Engagement Model Cascale, known previously as the Sustainable Apparel Coalition, is implementing a revolutionary member engagement and governance model aimed at ensuring comprehensive participation across its platform. This initiative emphasizes the vital role of suppliers and manufacturers, thereby enhancing decision-making processes within...

Continue Reading
Cosmic Crisp® Joins Forces with Dunford® for Delicious Pastries

Updated Category News Views 283

Cosmic Crisp® Collaborates with Dunford® for New Dessert Launch Cosmic Crisp® is making waves in the dessert market with an exciting collaboration with Dunford®, a brand celebrated for its exquisite pastries. Let’s explore this innovative partnership that introduces unique experiences for dessert lovers. The Launch of a New Pastry Delight The partnership between...

Continue Reading
Silexion Therapeutics Engages Investors with Public Offering

Updated Category News Views 138

Silexion Therapeutics Engages Investors with Public Offering Silexion Therapeutics Corp (NASDAQ: SLXN) is a clinical-stage biotech company focused on developing groundbreaking RNA interference (RNAi) therapies aimed at treating KRAS-driven cancers. Recently, the company announced closing a public offering priced at $1.35 per share, allowing investors to acquire a total of...

Continue Reading